Submitted by Anonymous (not verified) on 27 August 2026 - 14:06
Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 10, Status: Authorised
Source: